中文 | English
Return
Total: 49 , 1/5
Show Home Prev Next End page: GO
Author:(Shenglin MA)

1.Serum miRNA: a new marker of cancer diagnosis

Er JIN ; Shenglin MA

Journal of International Oncology 2012;39(9):678-679

2.GPRC5A and lung cancer

Er JIN ; Shenglin MA

Journal of International Oncology 2013;40(7):515-516

3.The progress of radiotherapy for brain gliomas

Chenhua ZHOU ; Shenglin MA

Cancer Research and Clinic 2001;0(04):-

4.Application of hypofractionated conformal radiotherapy in non-small cell lung cancer

Liming SHENG ; Yaping XU ; Shenglin MA

Journal of International Oncology 2011;38(5):374-376

5.Three-dimensional conformal radiotherapy for brain gliomas

Chenhua ZHOU ; Hong YE ; Shenglin MA

China Oncology 2000;0(06):-

6.The development of total body pan & scan radiotherapeutic instrument

Ciyong WANG ; Shenglin MA ; Songqing MA ; Dechu ZHU

Chinese Medical Equipment Journal 1989;0(03):-

7.An in vitro study of trophic activity on facial motoneuron by soluble substances derived from Schwann cells of rats

Xun MA ; Guangyan YU ; Zhenkang ZHANG ; Shenglin LI ; Kuihua ZHANG

Journal of Peking University(Health Sciences) 2001;33(2):127-131

8.The antiemetic effect of magnetotherapy in chemotherapy patients

Yan SUN ; Shenglin MA ; Aiqin ZHANG ; Yongjun ZHANG ; Wenlong BAO

Chinese Journal of Physical Medicine and Rehabilitation 2010;32(5):338-341

9.Prognosis and survival for 214 lung cancer patients with brain metastases

Meiyu FANG ; Shenglin MA ; Shengye WANG ; Yan SUN ; Yabing ZHENG

Chinese Journal of Neurology 2008;41(12):831-834

10.Research Progress in the mechanism of histone deacetylase inhibitors as radiosensitizers

Kan WU ; Zhibing WU ; Xufeng CHENG ; Shenglin MA

Journal of International Oncology 2014;41(6):425-428

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 49 , 1/5 Show Home Prev Next End page: GO